Li Z - Search Results

1

Radiation and resolve: unlocking the synergistic potential of radioimmunotherapy in advanced lung cancer management.

Zhang Y, Li Z, Zou B. Zhang Y, et al. Among authors: li z. Immunotherapy. 2024 Feb;16(2):55-58. doi: 10.2217/imt-2023-0268. Epub 2023 Dec 6. Immunotherapy. 2024. PMID: 38054261

2

Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.

Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Zhang Y, et al. Among authors: li z. Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023. Front Immunol. 2023. PMID: 37869003 Free PMC article. Review.

3

Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.

Zhang Y, Li Z, Huang Y, Xu Y, Zou B. Zhang Y, et al. Among authors: li z. Nanomedicine (Lond). 2023 Nov;18(27):2081-2099. doi: 10.2217/nnm-2023-0213. Epub 2023 Dec 11. Nanomedicine (Lond). 2023. PMID: 38078442 Review.

4

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.

Zhang Y, Liang L, Li Z, Huang Y, Jiang M, Zou B, Xu Y. Zhang Y, et al. Among authors: li z. Front Oncol. 2023 Dec 4;13:1295579. doi: 10.3389/fonc.2023.1295579. eCollection 2023. Front Oncol. 2023. PMID: 38111536 Free PMC article. Review.

5

Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.

Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Zhang Y, et al. Among authors: li z. BMJ Open. 2024 Jan 31;14(1):e073887. doi: 10.1136/bmjopen-2023-073887. BMJ Open. 2024. PMID: 38296306 Free PMC article.

6

Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC?

Li Z, Zhang Y, Li Y, Chen X, Hu J, Yu J, Hu Y, Nie S, Li N, Wen Q, Zou B. Li Z, et al. Among authors: li y, li n. Hepatology. 2024 Sep 1;80(3):E37-E38. doi: 10.1097/HEP.0000000000000803. Epub 2024 Feb 19. Hepatology. 2024. PMID: 38373119 No abstract available.

7

Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC.

Li Z, Zhang Y, Li Y, Lan J, Hu Y, Yu J, Meng Q, Zou B. Li Z, et al. Among authors: li y. Hepatology. 2024 Jun 1;79(6):E169-E170. doi: 10.1097/HEP.0000000000000812. Epub 2024 Mar 5. Hepatology. 2024. PMID: 38441957 No abstract available.

8

Prognostic significance of FAT10 expression in malignant tumors: a systematic review and meta-analysis.

Zhang Y, Li Z, Chen X, Huang Y, Zou B, Xu Y. Zhang Y, et al. Among authors: li z. Future Oncol. 2024;20(21):1505-1514. doi: 10.1080/14796694.2024.2357531. Epub 2024 Jun 12. Future Oncol. 2024. PMID: 38864667

9

Prognostic value of NOB1 expression levels in various cancers: a systematic review and meta-analysis.

Zhang Y, Li Z, Chen X, Huang Y, Zou B, Xu Y. Zhang Y, et al. Among authors: li z. Biomark Med. 2024;18(13-14):619-628. doi: 10.1080/17520363.2024.2352408. Epub 2024 Jun 17. Biomark Med. 2024. PMID: 38881528 Review.

10

Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions.

Zhang Y, Li Z, Huang Y, Xu Y, Zou B. Zhang Y, et al. Among authors: li z. Expert Rev Clin Immunol. 2024 Aug;20(8):971-984. doi: 10.1080/1744666X.2024.2368194. Epub 2024 Jun 17. Expert Rev Clin Immunol. 2024. PMID: 38884604 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,562 results

Search Page

Filters